Jeremy Friedman is Executive Vice President and Chief Operating Officer of Integer, one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. He is a member of Integer’s executive leadership team.
Friedman was named to this position in 2016, and is responsible for the medical segment of Integer, overseeing the Advanced Surgical & Orthopedic, Cardio & Vascular, and Cardiac Rhythm Management & Neuromodulation product categories. He is also responsible for the Supply Chain, Lean Enterprise, and Enterprise Health, Safety & Security functions.
Prior to this appointment, Friedman served as President of the Cardio & Vascular product category where he was responsible for driving profitable growth for the business, primarily focused on the vascular access, cardiovascular & structural heart, peripheral vascular, neurovascular, urology & oncology and electrophysiology markets.
Immediately prior to joining Accellent – now Integer – in 2007 as Chief Financial Officer, Friedman served with Flextronics in a number of finance and operational leadership roles, including Chief Operating Officer of Flextronics Network Services in Stockholm, Sweden.
He holds a Bachelor of Arts from Haverford College and a Master of Business Administration from Harvard University.
